Carl L. Gordon, Director, 10% Owner at Compass Therapeutics, Inc. (CMPX), bought 320,332 shares at $2.49 ($725K) on 2022-05-13, disclosed to the SEC on 2022-05-13.
Open-market purchase of $725k CMPX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.79 | 64,700 | $116K | 16.0% |
| 2 | $2.35 | 97,094 | $228K | 31.5% |
| 3 | $2.35 | 97,094 | $228K | 31.5% |
| 4 | $2.49 | 30,722 | $76K | 10.5% |
| 5 | $2.49 | 30,722 | $76K | 10.5% |
| Total | $2.26 avg | 320,332 |
| $725K |
| 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |